Related Experiment Video
Updated: Aug 31, 2025
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
1Department of Pathology, College of Medicine, Yeungnam University, Daegu 42415, Korea.
Biomedicines
|August 26, 2022
Summary
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare liver cancer with aggressive behavior. This review covers recent updates on cHCC-CCA classification, pathology, and diagnosis for improved patient outcomes.
Area of Science:
- Hepatobiliary pathology
- Tumorigenesis
- Diagnostic challenges in oncology
Background:
- Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer with dual hepatocytic and cholangiocytic differentiation.
- cHCC-CCA exhibits more aggressive behavior and poorer prognosis compared to classic hepatocellular carcinoma (HCC).
- Diagnostic challenges persist due to the morphologic and phenotypic diversity of cHCC-CCA.
Purpose of the Study:
- To review recent advances in understanding the biology of cHCC-CCA.
- To focus on updated tumor classification systems for cHCC-CCA.
- To highlight current diagnostic approaches for pathologists.
Main Methods:
- Literature review of recent studies on cHCC-CCA.
- Analysis of morphologic and phenotypic features.
- Synthesis of diagnostic criteria and classification updates.
Main Results:
- Recent advances have improved the understanding of cHCC-CCA biology.
- New insights into tumor classification and diagnostic markers are emerging.
- Standardized diagnostic approaches are crucial for accurate identification.
Conclusions:
- Accurate diagnosis of cHCC-CCA is critical for patient management and prognostication.
- Continued research into cHCC-CCA biology will refine diagnostic strategies.
- Pathologists require updated knowledge to address diagnostic challenges.
